Your Health, We Care
Sotorasib is indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an FDA-approved test, who have received at least one prior systemic therapy.
from FDA，2023.04
Sotorasib, also known as AMG-510, is an orally bioavailable drug that falls unde···【more】
Release date：2024-08-05Recommended：130
Sotorasib, a novel small molecule targeted therapeutic agent, presents a promisi···【more】
Release date：2024-08-05Recommended：143
Sotorasib, also known as AMG-510, is an orally bioavailable drug that falls unde···【more】
Release date：2024-07-09Recommended：165
